在严重的COVID-19中,MT2A缓冲耗尽标志着cuproptosis:多omics集成,计算建模和实验验证
Yuanshui Liu1, Feng Han1, Pinhua Pan2
1Department of Emergency Medicine, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan, China.
在严重的感染中,金属氨酸2A (MT2A) 的耗尽会导致铜的积累和细胞死亡. 这项研究揭示了潜在的COVID-19疗法的新氧化还原失衡网络.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 系统生物学 系统生物学
背景情况:
- 型亡是一种新型的依赖铜的细胞死亡途径,与线粒体代谢有关.
- 金属氨酸 (MT) 调节铜的平衡,但它们在严重感染中的作用尚不清楚.
- "铜缓冲-执行失衡"假设将MT2A的耗尽与铜积累和 cuproptosis通过FDX1-PDH轴联系起来.
研究的目的:
- 调查MT2A在严重感染期间铜恒温和铜的机制性作用.
- 为了阐明MT2A介导的"铜缓冲执行失衡"网络.
- 确定在严重的COVID-19中进行治疗干预的新型氧化还原检查点.
主要方法:
- 系统生物学方法集成in silico建模和实验验证.
- 来自PBMC,BALF和肺组织的多omics数据的分析.
- 虚拟淘汰赛模拟 (scTenifoldKnk) 和验证在一个LPS诱导的小鼠模型与LUS放射学.
主要成果:
- MT2A表达显示了组织特异性调节和双相动态 (上调调节跟随疲劳).
- 证明MT2A的枯竭会激活FDX1-PDH轴,从而引发cuproptosis.
- 卢斯放射学作为显微氧化损伤的宏观标记物出现.
结论:
- 该研究阐明了MT2A介导的"铜缓冲执行失衡"网络.
- 在严重的COVID-19中确定了潜在的治疗干预措施的新型氧化还原检查点.
- 突出了铜平衡,细胞死亡和感染之间的相互作用.
更多相关视频
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
相关概念视频
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Pneumothorax-II
Clinical Manifestations:
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Angle Closure Glaucoma: Treatment
